Target intelligence / Profile preview

Mitochondrial energy metabolism and redox systems

Molecular classification
Enzyme, Transporter, Metabolic pathway, Other
01

Overview

Mitochondrial energy metabolism and redox systems are the fundamental biochemical frameworks responsible for generating adenosine triphosphate (ATP) and maintaining cellular reduction-oxidation (redox) balance (Sies et al., 2017). These systems primarily operate through the tricarboxylic acid (TCA) cycle and the oxidative phosphorylation (OXPHOS) pathway, where electron transport chain (ETC) complexes create a proton gradient to drive ATP synthesis (Gorman et al., 2016). Beyond energy production, these systems are critical for regulating reactive oxygen species (ROS) levels, calcium signaling, and the initiation of apoptosis (Weinberg & Chandel, 2015). Dysregulation of mitochondrial bioenergetics is a key driver in various pathologies, including neurodegenerative diseases like Parkinson's and Alzheimer's, as well as metabolic disorders and cancer (Suomalainen et al., 2011). Pharmacological targeting of these systems involves modulating specific ETC complexes, utilizing mitochondrial-targeted antioxidants, or employing metabolic uncouplers to alter energy expenditure (Bridges et al., 2014). Because mitochondrial function is essential for nearly all eukaryotic cells, therapeutic interventions must be precisely calibrated to avoid systemic toxicity and metabolic collapse.

Other names
Mitochondrial bioenergeticsMitochondrial oxidative phosphorylation (OXPHOS) systemMitochondrial respiratory chainMitochondrial redox homeostasis
02

Mechanism of action

Modulation of electron transport chain (ETC) complexes, uncoupling of oxidative phosphorylation, and scavenging of reactive oxygen species (ROS) to restore metabolic homeostasis or induce apoptosis (Bridges et al., 2014; Sies et al., 2017).

03

Biological functions

ATP productionOxidative phosphorylationRedox signalingApoptosisCalcium homeostasisCell deathMetabolic regulation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseMetabolic syndromeInfectionMitochondrial diseaseAging
05

Safety considerations

Lactic acidosisMitochondrial toxicitySystemic metabolic disruptionNarrow therapeutic windowOrgan failure
06

Interacting drugs

Metformin

7 more in the full profile.

07

Biomarkers

Lactate/pyruvate ratioOxygen consumption rate (OCR)Extracellular acidification rate (ECAR)Mitochondrial DNA (mtDNA) copy numberGrowth differentiation factor 15 (GDF15)Fibroblast growth factor 21 (FGF21)

Beyond the preview

Go deeper on Mitochondrial energy metabolism and redox systems.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial energy metabolism and redox systems.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call